Alzheimer Disease (AD) linked to PUFA accumulation in brain

So much for the “beneficial” effects of PUFA. What makes this study particularly interesting is that it calls into question a favorite defensive maneuver of clinical nutritionists. Namely, when challenged about the known inflammatory effects of omega-6 fatty acids, most medical professionals make a desperate claim that omega-3 fatty acids are actually protective and we … Read more Alzheimer Disease (AD) linked to PUFA accumulation in brain

Low Dose Lithium May Stop Alzheimer’s Disease (AD) in Its Tracks

This study was sent to me by one of my Twitter followers. In some of my past interviews/podcasts, I did mention isolated published case studies, as well as anecdotal medical reports of even advanced cases of AD getting rapidly reversed by micro-dosing regimens using lithium salts such as aspartate or orotate. The doses reported by … Read more Low Dose Lithium May Stop Alzheimer’s Disease (AD) in Its Tracks

Metabolic dysfunction is a primary cause of aging and its symptom Alzheimer Disease (AD)

As it seems, not all hope is lost when it comes to mainstream medicine. Just a few days ago I posted about a landmark human study with AD demonstrating that the a low daily dose of the cheap, unpatentable chemical methylene blue (MB) may stop AD. LSD may do the same, and both MB and … Read more Metabolic dysfunction is a primary cause of aging and its symptom Alzheimer Disease (AD)

LSD enters clinical trials for Alzheimer Disease (AD)

For the last 5+ decades, Big Pharma and public health officials together with the entire law enforcement apparatus have been propagating myths, lies and outright fraud in regards to psychedelic drugs and especially about LSD. This attitude grew out of the civil rights movement and protests in the 1960s. During that time period a number … Read more LSD enters clinical trials for Alzheimer Disease (AD)

Increasing metabolism may reverse Alzheimer Disease (AD) and general aging

Yet another study demonstrating the remarkable parallels between the decline in function (metabolism) and the structural abnormalities that occur not only in specific pathologies such as AD but also in the generalized degradation known as “aging”. FDA currently does not recognize aging as a disease, but the evidence for it is rapidly accumulating. Just a … Read more Increasing metabolism may reverse Alzheimer Disease (AD) and general aging

Low-dose methylene blue (MB) may stop Alzheimer Disease (AD)

Another great result for the humble dye whose only claim medical fame so far has been as treatment for malaria, and even that “designation” has largely been deprecated due to the advent of new and “improved” drugs. About a decade ago, a company in the UK started researching MB as potential treatment for AD. Their … Read more Low-dose methylene blue (MB) may stop Alzheimer Disease (AD)

Allopregnanolone as a treatment of Alzheimer Disease (AD)

It looks like the recent FDA approval of allopregnanolone (ALLO) for postpartum depression may open the floodgates to ton of new research with this steroid, as well as with its reliable precursors such as pregnenolone and progesterone. I posted several studies in the past demonstrating that pregnenolone, progesterone and ALLO are all endotoxin antagonists and … Read more Allopregnanolone as a treatment of Alzheimer Disease (AD)